natgillin/translations-raw huggingface dataset:
Koldformede all- aluminium blisters (AAB), der består af en basisfolie af aluminium-polymer-laminat og et låg af aluminium-polymer-papirfolie i pakninger på 14 eller 28 smeltetabletter pr. karton.
Cold formed all-aluminium blisters (AAB) that consist of an aluminium-polymer laminate base foil and an aluminium-polymer-paper lidding foil in packs of 14 or 28 orodispersible tablets per carton.
Koldformede all- aluminium blisters (AAB), der består af en basisfolie af aluminium-polymer-laminat og et låg af aluminium-polymer-papirfolie i pakninger på 28 eller 98 smeltetabletter pr. karton.
Cold formed all-aluminium blisters (AAB) that consist of an aluminium-polymer laminate base foil and an aluminium-polymer-paper lidding foil in packs of 28 or 98 orodispersible tablets per carton.
Koldformede all- aluminium blisters (AAB), der består af en basisfolie af aluminium-polymer-laminat og et låg af aluminium-polymer-papirfolie i pakninger på 56 eller 98 smeltetabletter pr. karton.
Cold formed all-aluminium blisters (AAB) that consist of an aluminium-polymer laminate base foil and an aluminium-polymer-paper lidding foil in packs of 56 or 98 orodispersible tablets per carton.
Koldformede all-aluminium blisters (AAB)
EU/1/04/307/014
Koldformet aluminium/aluminiums perforeret enkeltdosisblister i æsker med 28 x 1 filmovertrukne tabletter pr. æske.
Cold-formed aluminium/aluminium perforated unit dose blisters in cartons of 28 x 1 film-coated tablets per carton
Koldformet aluminium/aluminiums perforeret enkeltdosisblister i æsker med 28 x 1 filmovertrukne tabletter pr. æske.
Cold-formed aluminium/aluminium perforated unit dose blisters in cartons of 28 x 1 film-coated tablets per carton.
Koldformet aluminium/aluminiums perforeret enkeltdosisblister i æsker med 28 x 1 og 98 x 1 filmovertrukne tabletter pr. æske.
Cold-formed aluminium/aluminium perforated unit dose blisters in cartons of 28 x 1 and 98 x 1 film- coated tablets per carton.
Koldformet aluminium/aluminiums perforeret enkeltdosisblister i æsker med 28 x 1, 56 x 1, 98 x 1 & 100 x 1 filmovertrukne tabletter pr. æske.
Cold-formed aluminium/aluminium perforated unit dose blisters in cartons of 28 x 1, 56 x 1, 98 x 1 and 100 x 1 film-coated tablets per carton.
Koldformet aluminium/aluminiumsperforeret blister i æsker med 10, 28, 30, 35, 56, 70 og multipakker med 70 (2 pakker med 35) filmovertrukne tabletter pr. æske.
Cold-formed aluminium/aluminium blister in cartons of 10, 28, 30, 35, 56, 70 and multipacks containing 70 (2 packs of 35) film-coated tablets per carton.
Koldformet aluminium/aluminiumsperforeret blister i æsker med 10, 28, 30, 35, 56, 70 og multipakker med 70 (2 pakker med 35) filmovertrukne tabletter pr. æske.
Cold-formed aluminium/aluminium blister in cartons of 7, 10, 28, 30, 35, 56, 70 and multipacks containing 70 (2 packs of 35) film-coated tablets per carton.
Koldsved
Cold sweat
Koldsved
cold sweats
Koldsved
Dysuria Pollakiuria
Koldsved Hævelser i ansigtet Generel pruritus Alopeci
Cold sweat Facial swelling Generalised pruritus Alopecia
Koldsved, halssammensnøring, opsvulmet tunge.
Cold sweat, tightness of the throat, swollen tongue
Koldsved, halssammensnøring, opsvulmet tunge.
Cold sweat, tightness of the throat, swollen tongue.
koldsved, hævet ansigt, generel kløe, hårtab, muskeltrækninger, muskelsvaghed, en følelse af ikke at have det godt, ubehag i brystet, tørst, man fryser eller har det varmt, besvær med at lade vandet
cold sweat, swollen face, generalised itching, hair loss, muscle twitching, muscular weakness, feeling unwell, chest discomfort, thirst, feeling cold, feeling hot, difficulty passing urine
koldsved, kraftig svedtendens
cold sweat, heavy sweating
koldsved; hedeture
cold sweats, hot flush
Kolecystektomi-hyppigheden for raloxifen (2,3 %) var ikke statistisk signifikant forskellig fra placebo (2,0 %).
Cholecystectomy rates for raloxifene (2.3 %) were not statistically significantly different from placebo (2.0 %).
kolecystit og cholelithiasis, hepatisk steatose,
cholecystitis and cholelithiasis, hepatic steatosis,
Kolelitiasis
Cholelithiasis
Kolestase
Cholestasis
kolestase (blokeret galdeflow fra leveren)
cholestasis (blocked bile flow from the liver)
Kolestase og kolecystitis
Cholestasis and cholecystitis
Kolestase, hepatomegali, hyperbilirubinæmi, gulsot, unormal leverfunktion, levertoksicitet, leversygdom, forhøjet gamma- glutamyltransferase
cholestasis, hepatomegaly, hyperbilirubinaemia, jaundice, hepatic function abnormal, hepatotoxicity, liver disorder, gamma-glutamyltransferase increased
kolestase, levertoksicitet, unormal leverfunktion
cholestasis, hepatic toxicity, hepatic function abnormal
Kolestase.
Cholestasis.
kolestatisk
cholestatic
kolestatisk eller
cholestatic or mixed liver injury)11
kolestatisk eller blandet leverskade) 11
Hepatitis (including hepatocellular, cholestatic or mixed liver injury) 11
kolestatisk eller blandet leverskade)11
cholestatic or mixed liver injury)11
kolestatisk eller blandet leverskade)11
Hepatitis (including hepatocellular, cholestatic or mixed liver injury)11
kolestatisk eller blandet leverskade)11
hepatocellular, cholestatic or mixed liver injury)11
Kolestatisk hepatitis
hepatitis cholestatic
Kolestatisk hepatitis (sjælden)
Cholestatic hepatitis (rare)
Kolestatisk hepatitis‡
Cholestatic hepatitis
Kolesterol 7-hydroxylase (CYP7A1)- mangel
Cholesterol 7-hydroxylase (CYP7A1) deficiency
Kolesterol 7-hydroxylase (CYP7A1)- mangel (n=1)
Cholesterol 7-hydroxylase (CYP7A1) deficiency (n=1)
kolesterol i blodet
mania, agitation,
kolesterol- niveauer2,3
Elevated glucose levels4
kolesterolniveauer2,3
levels2,3
kolesterolsænkende lægemidler (f.eks. atorvastatin)
medicines which lower cholesterol (e.g. atorvastatin)
kolesterolsænkende lægemidler - såsom statiner
medicines used to lower blood cholesterol - such as statins
Kolesterolsænkende lægemidler såsom colestyramin og colestipol kan påvirke optagelsen af cholsyre, hvilket ligeledes gælder visse aluminiumholdige syreneutraliserende midler (f.eks. midler mod fordøjelsesbesvær).
Medicines for lowering cholesterol levels in the blood, such as cholestyramine or colestipol and certain antacids which contain aluminium (e.g. indigestion relief products) may affect the absorption of cholic acid.
kolesterolsænkende lægemidler – såsom statiner,
medicines used to lower blood cholesterol - such as statins
kolesterolsænkende lægemidler, såsom:
cholesterol lowering medicines, such as:
kolestyramin 8 g 3 gange dagligt i 11 dage,
colestyramine 8 g is administered 3 times daily for a period of 11 days,
koliose (sideværts skævhed af rygsøjlen)
coliosis (deviation of the vertebral column)
kolitis (betændelse i tyktarmen)
colitis (inflammation of the colon)
kollaps
collapse
Kollaps (slaphed) eller perioder med bevidstløshed eller mangel på tilstedeværelse
Collapse (floppiness) or periods of unconsciousness or lack of awareness
Kollaps (slaphed) eller shock-lignende tilstand inden for 48 timer efter vaccination
A collapse (floppiness) or shock-like state within 48 hours of vaccination
Kollaps (slaphed) eller shock-lignende tilstand inden for 48 timer efter vaccination.
A collapse (floppiness) or shock-like state within 48 hours of vaccination
Kollaps eller chock-lignende tilstand (hypotonisk hyporesponsiv episode) indenfor 2 døgn efter vaccination
Collapse or shock-like state (hypotonic-hyporesponsiveness episode) within 48 hours of vaccination.
Kollaps eller chock-lignende tilstand (hypotonisk-hyporesponsiv episode) indenfor 2 døgn efter vaccination
Collapse or shock-like state (hypotonic-hyporesponsiveness episode) within 48 hours of vaccination.
kollaps eller chok-lignende tilstand med hypotonisk-hyporesponsiv episode (mistet energi) inden for 48 timer efter vaccination.
collapse or shock-like state with hypotonic-hyporesponsive episode (drop in energy) within 48 hours of vaccination.
kollaps eller perioder med bevidsthedstab eller mangel på koncentration er rapporteret indenfor 2 til 3 dage efter vaccination længere mellemrum mellem vejrtrækningerne hos meget tidligt fødte børn (født i uge 28 eller før af svangerskabet) kan forekomme 2-3 dage efter vaccination
collapse or periods of unconsciousness or lack of awareness have been reported within 2 to 3 days after vaccination in babies born very prematurely (at or before 28 weeks of gestation) longer gaps than normal between breaths may occur for 2-3 days after vaccination
Kollaps eller shock-lignende tilstand (hypotonisk-hyporesponsiv episode [HHE]) inden for 48 timer efter vaccination
Collapse or shock-like state (hypotonic-hyporesponsive episode [HHE]) within 48 hours of vaccination
Kollaps eller shock-lignende tilstand (hypotonisk-hyporesponsiv episode) inden for 48 timer efter vaccination;
Collapse or shock-like state (hypotonic-hyporesponsive episode) within 48 hours of vaccination;
Kollaps eller shock-lignende tilstand (hypotonisk-hyporesponsiv episode) inden for 48 timer efter vaccinationen;
Collapse or shock-like state (hypotonic-hyporesponsive episode) within 48 hours of vaccination;
Kollaps eller shock-lignende tilstand (hypotonisk-hyporesponsiv episode) inden for 48 timer efter vaccinationen;
Collapse or shock-like state (hypotonic-hyporesponsiveness episode) within 48 hours of vaccination;
Kollaps eller shock-lignende tilstand (hypotonisk-hyporesponsiv episode) inden for 48 timer.
Collapse or shock-like state (hypotonic-hyporesponsive episode) within 48 hours.
kollaps eller shock-lignende tilstand inden for 48 timer efter vaccinationen
a collapse or ‘shock-like’ state within 48 hours of vaccination
kollaps eller shock-lignende tilstand inden for 48 timer efter vaccinationen
a collapse or “shock-like” state within 48 hours of vaccination
Kollaps eller shock-lignende tilstand indenfor 48 timer efter vaccinationen.
A collapse or shock-like state within 48 hours of vaccination
Kollaps eller shocklignende tilstand (bevidstløshed/kontaktløshed)
Collapse or shock-like state (hypotonic-hyporesponsive episode)
Kollaps eller shocklignende tilstand (hypoton-hyporesponsiv episode)2
Collapse or shock-like state (hypotonic- hyporesponsive episode)2
Kollaps eller shocklignende tilstand (hypotonisk-hyporesponsiv episode)
Collapse or shock-like state (hypotonic-hyporesponsiveness episode)
Kollaps eller shok-lignende tilstand (hypotonic-hyporesponsive episode)
Collapse or shock-like state (hypotonic-hyporesponsive episode)
Kollaps på grund af alvorligt nedsat blodtryk
Collapse due to severe low blood pressure
Kolloid silica (E 551)
Colloidal silicon dioxide(E551)
Kolloid silica Natriumstearylfumarat Magnesiumstearat
Croscarmellose sodium Colloidal hydrated silica Sodium stearyl fumarate Magnesium stearate
Kolloid silica Prægelatineret majsstivelse Rød og gul jernoxid (E172).
Red and yellow ferric oxides (E172)
Kolloid siliciumdioxid (E551) Magnesiumstearat (E578) Mannitol (E421) Mikrokrystallinsk cellulose (E460) Povidon (E1201)
Colloidal silicon dioxide (E551) Magnesium stearate (E578) Mannitol (E421) Microcrystalline cellulose (E460) Povidone (E1201)
Kolloid vandfri silica
Magnesium stearate Colloidal anhydrous silica
Kolloid vandfri silica
Silica, colloidal anhydrous
Kolloid vandfri silica
Tablet film-coat: Hypromellose
Kolloid vandfri silica (E 551) Magnesiumstearat (E 470b)
Colloidal anhydrous silica (E 551) Magnesium stearate (E 470b)
Kolloid vandfri silica (E551) Magnesiumstearat (E470b)
Colloidal anhydrous silica (E551) Magnesium stearate (E470b)
Kolloid vandfri silica (E551) Natriumstearylfumarat
Colloidal anhydrous silica (E551) Sodium stearyl fumarate
Kolloid vandfri silica Brilliant blue FCF (E133) Sort jernoxid (E172)
Colloidal anhydrous silica Brilliant blue FCF (E 133) Ferric oxide black (E172) Ferric oxide yellow (E172) Magnesium stearate
Kolloid vandfri silica Brilliant blue FCF (E133) Sort jernoxid (E172)
Colloidal anhydrous silica Brilliant blue FCF (E133)
Kolloid vandfri silica Lactose, vandfri Magnesiumstearat (E 470b)
Silica, colloidal anhydrous Lactose anhydrous Magnesium stearate
Kolloid vandfri silica Lactosemonohydrat Magnesiumstearat (E 470b)
Silica, colloidal anhydrous Lactose anhydrous Magnesium stearate
Kolloid vandfri silica.
Colloidal anhydrous silica
Kolloid, vandfri silica Filmovertræk
Colloidal anhydrous silica Film coat
Kolloid-vandfrit silika.
Colloidal anhydrous silica.
Kolloider og hydroxyethyl- stivelsesesvæsker foretrækkes, idet disse er mindst tilbøjelige til at sive ud i det vaskulære system.
Colloids and hydroxyethyl starch fluids are preferred, as they are less likely to leak out of the vascular system.
Kolloidt siliconedioxid Jernoxider (E172)
Silica, colloidal anhydrous Iron Oxides (E172)
Kolon, kolorektalkræft og fremskreden ventrikelkræft, metaanalyse
Colon, colorectal and advanced gastric cancer: meta-analysis
kolorektal cancer (kræft i tyktarm/endetarm), der har spredt sig til andre dele af kroppen gastrointestinale stromale tumorer (GIST – en form for kræft i mave og tarm), som har spredt sig og ikke kan fjernes ved operation.
colorectal cancer (cancer of the bowel and rectum) that has spread to other parts of the body gastrointestinal stromal tumour (GIST -, a cancer of the stomach and bowel) that has spread and cannot be surgically removed.
Koloskopi anbefales til alle børn efter et års behandling og mindst hver 5. år derefter ved kontinuerlig behandling med Revestive.
Colonoscopy is recommended for all children after one year of treatment, and at least every 5 years thereafter of continuous treatment with Revestive.
Kom den brugte injektionssprøjte i den brudsikre beholder og anbring beholderen utilgængeligt for børn.
Put used syringes into the puncture-proof container and keep this container out of the sight and reach of children.
Kom den brugte sprøjte i den brudsikre beholder og anbring beholderen utilgængeligt for børn.
Put used syringes into the puncture-proof container and keep this container out of the sight and reach of children.
Kom det ordinerede antal tabletter i medicinbægret.
Place the prescribed number of tablets in the medicine cup.
Kom godt i gang!
Get a good start
Kom godt i gang!
Getting off to a good start
Kom ikke hoveddelen i vand.
Do not put the base in water.
Koma
syndrome
Koma (kan forekomme hos op til 1 ud af 100 personer) – et bevidstløshedsniveau, hvor det er svært at få et respons fra personen eller få personen til at vågne op.
Coma (may affect up to 1 in 100 people) – a state of unconsciousness with difficulty responding or waking up.
koma på grund af dårligt kontrolleret diabetes mellitus, unormal koordination, hovedrysten.
coma due to uncontrolled diabetes, abnormal coordination, shaking of the head
Koma, blødning i hjernen, slagtilfælde, lammelse, forandringer i hjernen, tale- og sprogforstyrrelser, hukommelsesproblemer
Coma, bleeding in the brain, stroke, paralysis, brain disorder, speech and language abnormalities, memory problems
Koma, blødning i hjernen, slagtilfælde, lammelse, hjerneforstyrrelse, tale- og sprogforstyrrelser, hukommelsesproblemer
coma, bleeding in the brain, stroke, paralysis, brain disorder, speech and language abnormalities, memory problems
koma, heriblandt
coma, including
Koma, konvulsioner, facialisparese
Coma, convulsions, facial palsy
Kombination af aliskiren og ARB’er eller ACE-hæmmere er kontraindiceret til patienter med diabetes mellitus eller nedsat nyrefunktion (GFR
The combination of aliskiren with ARBs or ACEIs is contraindicated in patients with diabetes mellitus or renal impairment (GFR
Kombination af andre antiretrovirale lægemidler med enkelt-dosis-nevirapin sænker forekomsten af nevirapinresistens.
Combination of other antiretrovirals with single-dose nevirapine attenuates the emergence of nevirapine resistance.
Kombination af avanafil og
adverse events (including visual
Kombination af Avastin med en anden medicin, sunitinibmalat (ordineret til kræft i nyrerne eller mave- tarmkanalen) kan forårsage alvorlige bivirkninger.
Combinations of Avastin with another medicine called sunitinib malate (prescribed for renal and gastrointestinal cancer) may cause severe side effects.
Kombination af bedaquilin og
Due to the risk of bedaquiline
Kombination af bedaquilin og
Due to the risk of bedaquiline related
Kombination af dette lægemiddel med ribavirin og boceprevir anbefales til brug ved nogle typer af kronisk hepatitis C virus-infektion (kaldes også hcv-infektion) hos voksne i alderen 18 år og ældre.
The combination of this medicine, ribavirin and boceprevir is recommended for use for some types of chronic hepatitis C virus infection in adults 18 years of age and older (also called HCV infection).
Kombination af dette lægemiddel med ribavirin og boceprevir anbefales til brug ved nogle typer afkronisk hepatitis C virus-infektion (kaldes også hcv-infektion) hos voksne i alderen 18 år og ældre.
The combination of this medicine, ribavirin and boceprevir is recommended for use for some types of chronic hepatitis C virus infection in adults 18 years of age and older (also called HCV infection).
Kombination af dette lægemiddel med ribavirin og boceprevir anbefales til brug ved nogle typer kronisk hepatitis C virus-infektion (kaldes også hcv-infektion) hos voksne i alderen 18 år og ældre.
The combination of this medicine, ribavirin and boceprevir is recommended for use for some types of chronic hepatitis C virus infection (also called HCV infection) in adults 18 years of age and older.
Kombination af emtricitabin og tenofovirdisoproxil
Combination of emtricitabine and tenofovir disoproxil
Kombination af emtricitabin og tenofovirdisoproxilfumarat: I studier af en måneds varighed eller derunder af genotoksicitet og af toksicitet efter gentagne doser med en kombination af disse to indholdsstoffer blev der ikke fundet nogen forværring af toksikologiske virkninger, sammenlignet med studier med de separate indholdsstoffer.
Combination of emtricitabine and tenofovir disoproxil fumarate: Genotoxicity and repeated dose toxicity studies of one month or less with the combination of these two components found no exacerbation of toxicological effects compared to studies with the separate components.
Kombination af emtricitabin og tenofovirdisoproxilfumarat: I studier af en måneds varighed eller derunder af genotoksicitet og af toksicitet efter gentagne doser med en kombination af disse to indholdsstoffer blev der ikke fundet nogen forværring af toksikologiske virkninger, sammenlignet med studier med de separate indholdsstoffer.
Combination of emtricitabine and tenofovir disoproxil fumarate: Genotoxicity and repeated-dose toxicity studies of one month or less with the combination of these two components found no exacerbation of toxicological effects compared to studies with the separate components.
kombination af et af disse
combining one of these
kombination af feber, muskelstivhed, hurtigere vejrtrækning, sveden, nedsat bevidsthed og pludselige ændringer i blodtryk og hjerterytme;
combination of fever, muscle stiffness, faster breathing, sweating, reduced consciousness and sudden changes in blood pressure and heart rate;
kombination af feber, muskelstivhed, hurtigere vejrtrækning, svedtendens, nedsat bevidsthed og pludselige ændringer i blodtryk og hjerterytme, besvimelse (malignt neuroleptisk syndrom),
combination of fever, muscle stiffness, faster breathing, sweating, reduced consciousness and sudden changes in blood pressure and heart rate, fainting (neuroleptic malignant syndrome),
Kombination af Humira og abatacept anbefales ikke (see section 4.4 se pkt.t 4.4 “Samtidig administration af biologiske DMARDs eller TNF-antagonister”).
The combination of Humira and abatacept is not recommended (see section 4.4 “Concurrent administration of biologic DMARDS or TNF-antagonists”).
Kombination af Kaletra med atorvastatin anbefales ikke.
The combination of Kaletra with atorvastatin is not recommended.
Kombination af Kaletra med:
The combination of Kaletra with:
Kombination af lithium og Ifirmacombi frarådes (se pkt.
The combination of lithium and Ifirmacombi is not recommended (see section 4.5).
Kombination af lithium og Irbesartan/Hydrochlorthiazid Teva frarådes (se pkt.
The combination of lithium and Irbesartan/Hydrochlorothiazide Teva is not recommended (see section 4.5).
Kombination af lopinavir/ritonavir med:
The combination of lopinavir/ritonavir with:
Kombination af macitentanog stærke CYP3A4-induktorer (f.eks. rifampicin, hypericum perforatum, carbamazepin og phenytoin) bør undgås (se pkt.
The combination of macitentan with strong CYP3A4 inducers (e.g., rifampicin, St. John’s wort, carbamazepine, and phenytoin) should be avoided (see section 4.5).
Kombination af omfattende svært udslæt, følelse af at være syg, feber, højt indhold af visse hvide blodlegemer eller gul hud eller øjne (tegn på gulsot) med stakåndethed, brystsmerter/ubehag, svært nedsat urinproduktion og tørst osv. (tegn på en behandlingsrelateret allergisk reaktion).
Combination of a widespread severe rash, feeling sick, fever, high level of certain white blood cells or yellow skin or eyes (signs of jaundice) with breathlessness, chest pain/discomfort, severely decreased urine output and feeling thirsty etc. (signs of a treatment-related allergic reaction).
kombination af ondt i halsen og løbende næse – dette kan være tegn på forkølelse (nasofaryngitis).
combination of sore throat and runny nose - these may be signs of nasopharyngitis.
Kombination af ondt i halsen og løbende næse – disse kan være tegn på forkølelse
Combination of sore throat and runny nose – these may be signs of nasopharyngitis
Kombination af REYATAZ og atorvastatin frarådes (se pkt.
The combination of REYATAZ with atorvastatin is not recommended (see section 4.5).
Kombination af Simponi og andre biologiske lægemidler til behandling af de samme lidelser som
The combination of Simponi with other biological therapeutics used to treat the same conditions as
Kombination af ZYPREXA og følgende medicin kan medføre, at du føler dig døsig: Medicin, der anvendes til behandling af angst eller søvnløshed (beroligende medicin, herunder benzodiazepiner) og medicin mod depression.
A combination of ZYPREXA with the following medicines might make you feel drowsy: medicines taken for anxiety or to help you sleep (tranquillisers, including benzodiazepines), and antidepressants.
Kombination af øm hals, hævede eller røde mandler, hoste, problemer med at synke og hovedpine (halsbetændelse), ses mindre hyppigt hos patienter med urinsyregigt.
Combination of sore throat, fever, swollen or red tonsils, cough, difficulty to swallow and headache (tonsilitis), reported less frequently in gouty arthritis patients.
kombination af ømhed i halsen og løbende næse
combination of sore throat and runny nose
Kombination der kræver forsigtighedsregler vedrørende brugen
Combination requiring precautions for use
kombination kan anvendes
combination can be used
kombination med
co-administered with
kombination med
Contraindicated in combination with
kombination med
doses of combination not established.
Kombination med anden behandling
Combinationswith other treatments
Kombination med andre behandlinger såsom kemoterapi eller immunsuppressive midler
Combination with other therapies like chemotherapy or immunosuppressive agents
Kombination med andre lægemidler, der kan påvirke immunsystemet og med vaccinationer Samtidig administration af ORENCIA og biologiske immunsuppressive eller immunmodulerende stoffer kan forstærke abatacepts effekt på immunsystemet.
Combination with other medicinal products that affect the immune system and with vaccinations Co-administration of ORENCIA with biologic immunosuppressive or immunomodulatory agents could potentiate the effects of abatacept on the immune system.
Kombination med andre lægemidler, der påvirker immunsystemet
Combination with other medicinal products that affect the immune system
kombination med boostet
monitoring is recommended when combined with boosted PREZISTA.
kombination med cobicistat
Buprenorphine/naloxone in combination with cobicistat
Kombination med direkte aktive antivirale lægemidler
Combination with direct acting antiviral agents
kombination med elvitegravir, skal
combination with elvitegravir, the
kombination med et andet
combination with another
Kombination med et glitazon
Combination with a thiazolidinedione
kombination med etravirin +
PI; except in combination with